Zymeworks

From WikiMD's Wellness Encyclopedia

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia

Zymeworks Logo.svg

Products and areas of focus[edit | edit source]

Zymeworks develops protein therapeutics for the treatment of:

  1. cancer
  2. autoimmune diseases and
  3. inflammatory diseases.

Molecular modelling[edit | edit source]

The products are based upon the company's molecular modeling software for optimizing protein structure.

Funding[edit | edit source]

  • In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year.
  • In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million.
  • This was the largest Canadian biotech IPO in more than a decade.

Trivia[edit | edit source]

By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.

Leadership[edit | edit source]

Website[edit | edit source]


Contributors: Prab R. Tumpati, MD